Xi'an International Medical Investment Company Limited (SHE:000516)
China · Delayed Price · Currency is CNY 4.660
+0.030 (0.65%)
May 8, 2026, 3:04 PM CST
SHE:000516 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | -363.01 | -421.03 | -254.13 | -368.36 | -1,177 | -822.17 |
Depreciation & Amortization | 688.03 | 688.03 | 706.86 | 769.89 | 620.31 | 568.64 |
Other Amortization | 17.11 | 17.11 | 38.3 | 13.94 | 12.97 | 8.77 |
Loss (Gain) From Sale of Assets | -0.18 | -0.18 | -1.66 | -1.95 | -7.25 | 0.17 |
Asset Writedown & Restructuring Costs | 8.62 | 8.62 | 2.59 | 0.87 | 3.36 | 1.9 |
Loss (Gain) From Sale of Investments | -33.96 | -33.96 | -23.77 | -73.86 | 63.33 | 65.3 |
Provision & Write-off of Bad Debts | - | - | 5.75 | 15.55 | 6.93 | 5.93 |
Other Operating Activities | 66.45 | 118.81 | 64.67 | 122.7 | 181.67 | 166.51 |
Change in Accounts Receivable | 177.74 | 177.74 | -133.05 | -285.53 | 142.34 | -44.09 |
Change in Inventory | 13.78 | 13.78 | -2.67 | -9.1 | 10.63 | -26.63 |
Change in Accounts Payable | 695.04 | 695.04 | 589.74 | 867.72 | 511.94 | 486.85 |
Change in Other Net Operating Assets | - | - | 6.66 | 32.81 | 37.08 | 135.89 |
Operating Cash Flow | 1,282 | 1,276 | 1,009 | 1,087 | 461.34 | 456.34 |
Operating Cash Flow Growth | 24.04% | 26.49% | -7.19% | 135.69% | 1.10% | 1004.15% |
Capital Expenditures | -156.41 | -262.47 | -547.74 | -762.67 | -1,188 | -1,660 |
Sale of Property, Plant & Equipment | 34.19 | 34.19 | 0.5 | - | 97.24 | 0.48 |
Divestitures | - | - | - | - | 160 | - |
Investment in Securities | 10.65 | 87.92 | 39 | 21.36 | 89 | 417.66 |
Other Investing Activities | 16.9 | 13.24 | 2.06 | -20.68 | 23.62 | 41.98 |
Investing Cash Flow | -94.67 | -127.11 | -506.19 | -762 | -817.99 | -1,200 |
Long-Term Debt Issued | - | 493.01 | 717.48 | 796.76 | 802.79 | 1,175 |
Long-Term Debt Repaid | - | -1,593 | -1,372 | -1,061 | -565.18 | -914.98 |
Net Debt Issued (Repaid) | -1,062 | -1,100 | -654.68 | -264.22 | 237.61 | 259.73 |
Issuance of Common Stock | - | - | - | - | 32.55 | 1,201 |
Repurchase of Common Stock | - | - | - | - | -3.94 | - |
Common Dividends Paid | -138.63 | -149.21 | -183.72 | -217.4 | -245.42 | -232.34 |
Other Financing Activities | -13.48 | -59.38 | -59.94 | -83.52 | - | 75.01 |
Financing Cash Flow | -1,214 | -1,309 | -898.33 | -565.15 | 20.8 | 1,304 |
Net Cash Flow | -26.77 | -159.43 | -395.4 | -239.82 | -335.85 | 560.15 |
Free Cash Flow | 1,126 | 1,014 | 461.38 | 324.66 | -726.51 | -1,203 |
Free Cash Flow Growth | 114.00% | 119.78% | 42.11% | - | - | - |
Free Cash Flow Margin | 27.82% | 24.89% | 9.58% | 7.03% | -26.80% | -41.20% |
Free Cash Flow Per Share | 0.51 | 0.45 | 0.20 | 0.14 | -0.32 | -0.54 |
Cash Income Tax Paid | 71.25 | 72.29 | 79.34 | 72.34 | -159.63 | -170.39 |
Levered Free Cash Flow | 513.83 | 368.72 | -434.23 | -494.1 | -1,406 | -931.78 |
Unlevered Free Cash Flow | 513.83 | 368.72 | -325.88 | -357.2 | -1,287 | -812.55 |
Change in Working Capital | 899.05 | 899.05 | 470.51 | 608.56 | 756.7 | 461.29 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.